Surgical treatment of subependymal giant cell astrocytoma in tuberous sclerosis complex patients

Pediatric Neurology

Volumn 50, Issue 4, 2014, Pages 307-312

  Kotulska, Katarzyna ^a   Borkowska, Julita ^a   Roszkowski, Marcin ^a   Mandera, Marek ^b   Daszkiewicz, Paweł ^a   Drabik, Krzysztof ^a   Jurkiewicz, Elzbieta ^a   Larysz Brysz, Magdalena ^b   Nowak, Katarzyna ^a   Grajkowska, Wiesława ^a   Domańska Pakieła, Dorota ^a   Jóźwiak, Sergiusz ^a  

^a CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

mTOR inhibitors; outcome; prognostic factor; subependymal giant cell astrocytoma; surgery; tuberous sclerosis complex

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; TUBERIN; TUBEROUS SCLEROSIS COMPLEX 1 PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ADOLESCENT; AGE; ARTERIOVENOUS SHUNT; ARTICLE; BRAIN HEMATOMA; BRAIN HEMORRHAGE; CANCER SURGERY; CHILD; COGNITIVE DEFECT; DIABETES INSIPIDUS; EPILEPTIC STATE; FEMALE; FOLLOW UP; GENE; GENE MUTATION; HEADACHE; HEART ARREST; HEMIPARESIS; HUMAN; HYDROCEPHALUS; MAJOR CLINICAL STUDY; MALE; MENINGITIS; NEUROPATHIC HEADACHE; NEUROPATHY; NEUROSURGERY; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PRECOCIOUS PUBERTY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEIZURE; SUBEPENDYMAL GIANT CELL ASTROCYTOMA; SURGERY; SURGICAL MORTALITY; SURGICAL RISK; TREATMENT INDICATION; TSC1 GENE; TSC2 GENE; TUBEROUS SCLEROSIS; TUMOR VOLUME; ADULT; ASTROCYTOMA; BRAIN; BRAIN NEOPLASMS; COMPLICATION; GENETICS; INFANT; MUTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; RISK FACTOR; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; ASTROCYTOMA; BRAIN; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MAGNETIC RESONANCE IMAGING; MALE; MUTATION; NEUROSURGICAL PROCEDURES; RISK FACTORS; TREATMENT OUTCOME; TUBEROUS SCLEROSIS; TUMOR SUPPRESSOR PROTEINS; YOUNG ADULT;

EID: 84896390565     PISSN: 08878994     EISSN: 18735150     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2013.12.004     Document Type: Article

References (31)

1. R.A. Schwartz, G. Fernandez, K. Kotulska, and S. Jozwiak Tuberous sclerosis complex: advances in diagnosis, genetics, and management J Am Acad Dermatol 57 2007 189 202 (Pubitemid 47048880)
2. D.J. Kwiatkowski Rhebbing up mTOR: new insights on TSC1 and TSC2, and the pathogenesis of tuberous sclerosis Cancer Biol Ther 2 2003 471 476
3. J.A. Chan, H. Zhang, and P.S. Roberts et al. Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation J Neuropathol Exp Neurol 63 2004 1236 1242 (Pubitemid 39603395)
4. J.P. Osborne, A. Fryer, and D. Webb Epidemiology of tuberous sclerosis Ann N Y Acad Sci 615 1991 125 127
5. P. Curatolo, R. Bombardieri, and S. Jozwiak Tuberous sclerosis Lancet 372 2008 657 668
6. W. Grajkowska, K. Kotulska, and E. Jurkiewicz et al. Brain lesions in tuberous sclerosis complex Review. Folia Neuropathol 48 2010 139 149
7. M.A.E.P. Adriaensen, C.M. Schaefer-Prokop, and T. Stijnen et al. Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature Eur J Neurol 16 2009 691 696
8. S.K. Kim, K.C. Wang, and B.K. Cho et al. Biological behavior and tumorigenesis of subependymal giant cell astrocytomas J Neurooncol 52 2001 217 225
9. C. Di Rocco, A. Ianelli, and E. Marchese On the treatment of subependymal giant cell astrocytomas and associated hydrocephalus in tuberous sclerosis Pediatr Neurosurg 23 1995 115 121
10. C.W. Shepherd, M.R. Gomez, J.T. Lie, and C.S. Crowson Causes of death in patients with tuberous sclerosis Mayo Clin Proc 66 1991 792 796
11. D.A. Krueger, M.M. Care, and K. Holland et al. Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis N Engl J Med 363 2010 801 1811
12. D.N. Franz, E. Belousova, and S. Sparagana et al. Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial Lancet 381 2013 125 132
13. C. Lam, E. Bouffet, and U. Tabori et al. Rapamycin (sirolimus) in tuberous sclerosis associated pediatric central nervous system tumors Pediatr Blood Cancer 54 2009 476 479
14. T.L. Beaumont, D.D. Limbrick, and M.D. Smyth Advances in the management of subependymal giant cell astrocytoma Childs Nerv Syst 28 2012 963 968
15. J. Roth, E.S. Roach, and U. Bartels et al. Subependymal giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the International Tuberous Sclerosis Complex Consensus Conference 2012 Pediatr Neurol 49 2013 439 444
16. S. Jóźwiak, R. Nabbout, and P. Curatolo Management of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC): clinical recommendations Eur J Paediatr Neurol 17 2013 348 352
17. K. Kotulska, D. Chmielewski, and J. Borkowska et al. Long-term effect of everolimus on epilepsy and growth in children under 3 years of age treated for subependymal giant cell astrocytoma associated with tuberous sclerosis complex Eur J Paediatr Neurol 17 2013 479 485
18. K. Kotulska, J. Borkowska, and S. Jozwiak Possible prevention of tuberous sclerosis complex lesions Pediatrics 132 2013 e239 e242
19. P. Sun, D. Krueger, and J. Liu et al. Surgical resection of subependymal giant cell astrocytomas (SEGAs) and changes in SEGA-related conditions: a US national claims database study Curr Med Res Opin 28 2012 1 6
20. S. de Ribaupierre, G. Dorfmüller, and C. Bulteau et al. Subependymal giant-cell astrocytomas in pediatric tuberous sclerosis disease: when should we operate? Neurosurgery 60 2007 83 89 (Pubitemid 46102922)
21. S. Amin, M. Carter, and R. Edwards et al. The outcome of surgical management of subependymal giant cell astrocytoma in tuberous sclerosis complex Eur J Paediatr Neurol 17 2013 36 44
22. I. Pascual-Castroviejo Neurosurgical treatment of tuberous sclerosis complex lesions Childs Nerv Syst 27 2011 1211 1219
23. M. Berhouma Management of subependymal giant cell tumors in tuberous sclerosis complex: the neurosurgeon's perspective World J Pediatr 6 2010 103 110
24. V. Cuccia, G. Zuccaro, and F. Sosa et al. Subependymal giant cell astrocytoma in children with tuberous sclerosis Childs Nerv Syst 19 2003 232 243 (Pubitemid 36798785)
25. O.A. Torres, E.S. Roach, and M.R. Delgado et al. Early diagnosis of subependymal giant cell astrocytoma in patients with tuberous sclerosis J Child Neurol 13 1998 173 177 (Pubitemid 28222064)
26. R. Nabbout, M. Santos, and Y. Rolland et al. Early diagnosis of subependymal giant cell astrocytoma in children with tuberous sclerosis J Neurol Neurosurg Psychiatr 66 1999 370 375 (Pubitemid 29103492)
27. S. Goh, W. Butler, and E.A. Thiele Subependymal giant cell tumors in tuberous sclerosis complex Neurology 63 2004 1457 1461 (Pubitemid 39426281)
28. P. Sun, M. Kohrman, J. Liu, A. Guo, J. Rogerio, and D. Krueger Outcomes of resecting subependymal giant cell astrocytoma (SEGA) among patients with SEGA-related tuberous sclerosis complex: a national claims database analysis Curr Med Res Opin 28 2012 651 656
29. S.L. Dabora, S. Jozwiak, and D.N. Franz et al. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs Am J Hum Genet 68 2001 64 80 (Pubitemid 32048362)
30. C. Michelozzi, G. Di Leo, and F. Galli et al. Subependymal nodules and giant cell tumors in tuberous sclerosis complex patients: prevalence on MRI in relation to gene mutation Childs Nerv Syst 29 2013 249 254
31. J.R. Sampson, M.M. Maheshwar, and R. Aspinwall et al. Renal cystic disease in tuberous sclerosis: role of the polycystic kidney disease 1 gene Am J Hum Genet 61 1997 843 851 (Pubitemid 27418458)